Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOMILNACIPRAN Cause Osteoporosis? 20 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Osteoporosis have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 1.5% of all adverse event reports for LEVOMILNACIPRAN.

20
Reports of Osteoporosis with LEVOMILNACIPRAN
1.5%
of all LEVOMILNACIPRAN reports
20
Deaths
20
Hospitalizations

How Dangerous Is Osteoporosis From LEVOMILNACIPRAN?

Of the 20 reports, 20 (100.0%) resulted in death, 20 (100.0%) required hospitalization, and 20 (100.0%) were considered life-threatening.

Is Osteoporosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 20 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOMILNACIPRAN Cause?

Off label use (376) Drug ineffective (315) Gastrooesophageal reflux disease (295) Vomiting (294) Hypoaesthesia (290) Abdominal pain upper (285) Paraesthesia (282) Memory impairment (277) Blepharospasm (276) Taste disorder (276)

What Other Drugs Cause Osteoporosis?

EMTRICITABINE\TENOFOVIR DISOPROXIL (7,436) TENOFOVIR DISOPROXIL (5,302) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (4,029) ADALIMUMAB (2,665) PREDNISONE (2,476) METHOTREXATE (2,018) ETANERCEPT (1,766) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,720) TOCILIZUMAB (1,689) ALENDRONATE (1,688)

Which LEVOMILNACIPRAN Alternatives Have Lower Osteoporosis Risk?

LEVOMILNACIPRAN vs LEVONORGESTREL LEVOMILNACIPRAN vs LEVORPHANOL LEVOMILNACIPRAN vs LEVOSIMENDAN LEVOMILNACIPRAN vs LEVOSULPIRIDE LEVOMILNACIPRAN vs LEVOTHYROXINE

Related Pages

LEVOMILNACIPRAN Full Profile All Osteoporosis Reports All Drugs Causing Osteoporosis LEVOMILNACIPRAN Demographics